AUA 2025 Las Vegas, NV Current Fellows

Zachary Klaassen speaks with Vikram Narayan from Emory University about nadofaragene firadenovec, a first-in-class gene therapy for BCG-unresponsive bladder cancer. Dr. Narayan explains how this non-r...

Read the success stories of how health organizations around the world use Apple technology to reduce clinician burnout and deliver personalized care.

"There really aren’t many other places treating advanced bladder cancer the way we are,” says Shreyas Joshi, MD, MPH, a urologic oncologist at Winship Cancer Institute of Emory University. He speciali...

Prostate Cancer and Prostatic Diseases - Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer

Patient recruitment is challenging for clinical trials. Here, the authors introduce TrialGPT, an end-to-end framework for zero-shot patient-to-trial matching with large language models.